Apollo Endosurgery (APEN) has a profit margin of -51.84%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2022
Trailing 12 months ending Dec 2022
Apollo Endosurgery (APEN) currently reports a profit margin of -51.84% as of December 2022. That compares with -39.18% in the prior-year period — down 32.3% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Apollo Endosurgery's profit margin history and peer comparisons.
Apollo Endosurgery's profit margin decreased from -39.18% to -51.84% — a 32.3% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Apollo Endosurgery's profit margin of -51.84% is lower than the Healthcare sector average of 13.89%. That is roughly 473.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Apollo Endosurgery's current -51.84% should be judged against Healthcare norms (sector average: 13.89%) and against APEN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -51.84%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Apollo Endosurgery, and consider following APEN for alerts when major investors trade the stock.